Search 

We are a research-driven biotech company dedicated to the discovery of first-in-class therapies addressing unmet needs. Our platforms and portfolio deliver NCEs and protein therapeutics against novel targets of relevance in oncology and neurodegeneration.

Our exclusive focus on life sciences sets us apart. We partner with innovative companies who are dedicated to advancing medical care and improving lives worldwide. 

The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Bionow supports business growth, competitiveness and innovation within the biomedical and life science sectors across Northern England. Our membership services add value and cost-efficiency to scientific, clinical and business operations within early stage and growth-oriented firms. Our membership base includes startups and early stage firms as well as established growth-oriented companies. Bionow's membership offering focuses upon the specific needs of firms at their different stages of development, including dedicated business support programmes, shared procurement schemes with significant cost savings, exclusive insurance benefits, recruitment and training services, local and national events and access to a vibrant network of businesses.

BioPartner UK is a trade organisation that provides practical support and international promotion to UK Life Sciences companies, who wish to grow their business overseas. BioPartner signposts to UK expertise and leads delegations to promote the UK presence at major international biopharma conferences. Accredited by the Department of Business and Trade and working in partnership with the UK government and event organisers, BioPartner assists all UK companies with discounted entry fees. Members of the BioPartner Programme receive extra benefits and support to effectively trade overseas.

We have a highly valuable and differentiated approach to Drug Discovery through our enhanced candidate molecule design and patient stratification capabilities, generating small molecule drug candidates focused on immuno-inflammation.

We work with clients, who range from Top 5 Pharma companies to SMEs, to develop and execute innovative regulatory strategies from early product development to post-licensing activities for medicines and medical devices.

We pride ourselves on our understanding of clients’ needs and our flexible, creative and pragmatic approach puts our clients and the patients they serve at the centre of everything we do.

We are a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials, providing end-to-end early clinical development services for our broad and longstanding global client base of biopharma companies.